Literature DB >> 18075597

Small RNAs: delivering the future.

Nathan Blow.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 18075597     DOI： 10.1038/4501117a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  18 in total

Review 1.  MicroRNAs in neurodegenerative diseases and their therapeutic potential.

Authors:  Eunsung Junn; M Maral Mouradian
Journal:  Pharmacol Ther       Date:  2011-10-08       Impact factor: 12.310

2.  Amphiphilic and biodegradable methoxy polyethylene glycol-block-(polycaprolactone-graft-poly(2-(dimethylamino)ethyl methacrylate)) as an effective gene carrier.

Authors:  Shutao Guo; Yuanyu Huang; Tuo Wei; Wendi Zhang; Weiwei Wang; Daoshu Lin; Xu Zhang; Anil Kumar; Quan Du; Jinfeng Xing; Liandong Deng; Zicai Liang; Paul C Wang; Anjie Dong; Xing-Jie Liang
Journal:  Biomaterials       Date:  2010-10-20       Impact factor: 12.479

3.  Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs.

Authors:  Tian Xia; Michael Kovochich; Monty Liong; Huan Meng; Sanaz Kabehie; Saji George; Jeffrey I Zink; Andre E Nel
Journal:  ACS Nano       Date:  2009-10-27       Impact factor: 15.881

4.  Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer.

Authors:  Bo Wu; Hong M Moulton; Patrick L Iversen; Jiangang Jiang; Juan Li; Jianbin Li; Christopher F Spurney; Arpana Sali; Alfredo D Guerron; Kanneboyina Nagaraju; Timothy Doran; Peijuan Lu; Xiao Xiao; Qi Long Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-19       Impact factor: 11.205

5.  siRNA-based therapy ameliorates glomerulonephritis.

Authors:  Hideki Shimizu; Yuichi Hori; Shinya Kaname; Koei Yamada; Nobuhiro Nishiyama; Satoru Matsumoto; Kanjiro Miyata; Makoto Oba; Akira Yamada; Kazunori Kataoka; Toshiro Fujita
Journal:  J Am Soc Nephrol       Date:  2010-03-04       Impact factor: 10.121

Review 6.  Personalized cancer approach: using RNA interference technology.

Authors:  John Nemunaitis; Donald D Rao; Shi-He Liu; F Charles Brunicardi
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

7.  Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering RNA delivery.

Authors:  Jinjun Shi; Zeyu Xiao; Alexander R Votruba; Cristian Vilos; Omid C Farokhzad
Journal:  Angew Chem Int Ed Engl       Date:  2011-06-22       Impact factor: 15.336

Review 8.  Advances in nanotechnology for the management of coronary artery disease.

Authors:  June-Wha Rhee; Joseph C Wu
Journal:  Trends Cardiovasc Med       Date:  2012-12-13       Impact factor: 6.677

9.  Octa-guanidine morpholino restores dystrophin expression in cardiac and skeletal muscles and ameliorates pathology in dystrophic mdx mice.

Authors:  Bo Wu; Yongfu Li; Paul A Morcos; Timothy J Doran; Peijuan Lu; Qi Long Lu
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

10.  Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors.

Authors:  Justin P Dassie; Xiu-Ying Liu; Gregory S Thomas; Ryan M Whitaker; Kristina W Thiel; Katie R Stockdale; David K Meyerholz; Anton P McCaffrey; James O McNamara; Paloma H Giangrande
Journal:  Nat Biotechnol       Date:  2009-08-23       Impact factor: 54.908
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.